Last March, $IMMX 's management team and board hired a new chief medical officer who was living under a fake name after spending 20 years as a fugitive following a conviction for sexual assault.
Yesterday, the same Immix executives turned a positive study readout into an 8% drop in the stock price because of a clumsy financing and an amateur-hour conference call.
See a pattern here?
Show more
